You searched for viral vector - Page 23 of 53

News and Trends 23 Mar 2020

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in Canada, which could replace the need for daily antiretroviral pills….

March 23, 2020 - 2 minutesmins - By Jonathan Smith

Best in Biotech 4 Nov 2022

Get to know 15 of the best biotech companies in Paris

…to modulate the body’s immune system through its immune enhancing and antiviral platforms to treat chronic inflammatory diseases, viral infections and cancer. The company’s lead candidate entered phase 3 trials…

November 4, 2022 - 11 minutesmins - By Omnia Ibrahim

News and Trends 28 Jun 2022

Eiger BioPharmaceuticals presents liver study data

…showed Lambda therapy had better antiviral activity and tolerability compared to historical data for peginterferon alfa and identified four main HDV RNA kinetic patterns under Lambda therapy. Eiger said the…

June 28, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 15 Mar 2017

France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses

…possible biomarkers for reservoir cells and demonstrated in vitro that the elimination of cells with the CD32a protein could significantly reduce the viral production. A patent owned by the French…

March 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

…results. Its candidate, ABX464, caused a significant reduction of viral reservoirs over a 28-day period. The study included just 11 patients, with 9 completing the study and 8 of those…

December 18, 2017 - 9 minutesmins - By Alex Dale

News and Trends 15 Feb 2016

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

…Pharma Company. It’s celebrating its 10th birthday this year, which is good reason to interview the CEO… So AiCuris is working on anti-infective drugs for viral infection. It has 6…

February 15, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

…from therapies. “Vaccines are expected to eradicate a virus in the best case,” said Christian Setz, Managing Director of the German biotech ImmunoLogik, which is developing a broad-spectrum antiviral that…

November 25, 2021 - 6 minutesmins - By Victor Kotsev

In Depth 18 Apr 2023

Gene therapy: a powerful tool for hemophilia B?

…though the vector that is inserted is a non-integrating one – where the DNA in the human cell and the genetic material from the vector remain separate – and consequently…

April 18, 2023 - 10 minutesmins - By Roohi Mariam Peter

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

…VectorY Therapeutics. VectorY treats treat rare diseases of the central nervous system. Forbion established VectorY by combining the expertise, experience and vision of Forbion operating partners and industry leaders, Sander…

February 28, 2023 - 6 minutesmins - By External Contributor

News and Trends 5 Sep 2017

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

…vector technology, which the biotech licensed from the Institut Pasteur in Paris. Its Chikungunya vaccine is already in Phase II trials in Europe and will now enter a new Phase…

September 5, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 1 Jun 2023

Five ophthalmology biotech companies to look out for

…However, the ABCA4 gene is too large at 6.8kb for single adeno-associated virus (AAV) vectors to package enough genetic material to treat it, as AAV vectors can only package 4.7kb…

June 1, 2023 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 2 Sep 2021

The top 15 biotech companies to find in the Netherlands

…also received FDA approval for its gene therapy for hemophilia B, developed in partnership with CSL Behring. VectorY Therapeutics Founded: 2020 VectorY develops treatments that combine gene therapy and antibody…

September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

Get to know 15 of the best biotech companies in Paris

Eiger BioPharmaceuticals presents liver study data

France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

Gene therapy: a powerful tool for hemophilia B?

Life changing treatments for rare disease – a beacon of hope

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

Five ophthalmology biotech companies to look out for

The top 15 biotech companies to find in the Netherlands

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!